Notch1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Notch1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Notch1 is a transmembrane receptor protein encoded by the NOTCH1 gene. It is a member of the Notch family of receptors (Notch1-4 in mammals) that play fundamental roles in cell fate determination and development. Notch1 is a large type I transmembrane protein consisting of an extracellular domain (NECD), a transmembrane domain, and an intracellular domain (NICD). The protein undergoes proteolytic processing to generate a signaling molecule that translocates to the nucleus <sup>[1]</sup>.
In the nervous system, Notch1 is expressed in neural stem cells, differentiating [neurons](/entities/neurons), and some glial cells. It regulates key processes including neurogenesis, synaptic plasticity, and gliogenesis.
Structure
The Notch1 protein contains:
EGF-like repeats: 36 epidermal growth factor-like repeats in the extracellular domain, responsible for ligand binding
LIN-12/Notch repeats (LNR): Three LNR repeats that prevent signaling in the absence of ligand
ANK repeats: Six ankyrin repeats that mediate protein-protein interactions in the NICD
Function
Signaling Mechanism
Notch1 signaling is activated by ligand binding (Delta-like or Jagged family), which triggers:
S1 cleavage: Furin-mediated cleavage in the trans-Golgi network
S2 cleavage: ADAM10/TACE-mediated cleavage in the extracellular domain
S3/gamma-secretase cleavage: Release of the Notch intracellular domain (NICD)
The NICD translocates to the nucleus, where it associates with CSL (CBF1/RBP-Jkappa) transcription factors and co-activators (MAML1-4) to activate target genes.
Functions in the CNS
Neural stem cell maintenance: Notch1 maintains the undifferentiated state of neural progenitors
Neuronal differentiation: Regulates transition from progenitors to post-mitotic neurons
Synaptic plasticity: Modulates excitatory synaptic transmission and [LTP](/mechanisms/long-term-potentiation)
Astrocyte differentiation: Cooperates with other pathways to promote astrogliogenesis
Role in Disease
Alzheimer's Disease
Notch1 intersects with AD pathophysiology through:
Competition with [APP](/entities/app-protein) for [gamma-secretase](/entities/gamma-secretase)
Modulation of [amyloid-beta](/proteins/amyloid-beta) production
Regulation of synaptic gene expression
Neuroinflammation via microglial activation
Cancer
Notch1 is a known oncogene in T-cell acute lymphoblastic leukemia (T-ALL) and other cancers. Activating mutations in NOTCH1 are among the most common genetic alterations in T-ALL.
Therapeutic Targeting
Notch1 is a therapeutic target in both cancer and neurodegeneration:
Gamma-secretase inhibitors: Block S3 cleavage but affect APP processing
Notch-specific inhibitors: Monoclonal antibodies against the extracellular domain
Targeted degradation: PROTACs designed to degrade Notch1
The study of Notch1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Cross-links
NOTCH1 Gene
Notch Signaling Pathway
Gamma-secretase
APP Processing
References
Kopan R, Ilagan MX, The canonical Notch signaling pathway (2009)
Lathia JD, et al, Notch in the nervous system (2020)